Cabozer (Cabozantinib 40mg Tablet) is used to treat advanced kidney, liver, and thyroid cancers by blocking cancer cell growth and spread.
| Composition | Cabozantinib |
| Manufacturer | Aprazer |
| Packing | 30 Tablets |
| Prescribed For | Kidney, Liver, and Thyroid Cancers |
| Expiry | December 2027 |
Lenakast (Lenalidomide 25 mg) is an oral immunomodulatory medicine used in the treatment of multiple myeloma and certain blood disorders. It helps slow cancer cell growth, supports immune response, and is commonly used as part of combination therapy under medical supervision.
| Composition | Lenalidomide |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 30 Capsules in 1 Bottle |
| Prescribed For | Multiple myeloma |
| Expiry | December 2027 |
Olabir is an oral anticancer medication containing Olaparib 150 mg, a PARP inhibitor used to treat cancers associated with BRCA gene mutations. It is commonly prescribed for ovarian, breast, pancreatic, and prostate cancers, helping to slow cancer progression and improve survival in advanced stages.
| Composition | Olaparib |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 30 Tablets in 1 bottle |
| Prescribed For | Ovarian and Breast Cancer |
| Expiry | December 2027 |
Imatikast contains Imatinib 400mg, a targeted cancer therapy used to treat certain types of cancers such as Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and Gastrointestinal Stromal Tumors (GISTs).
| Composition | Imatinib |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 10 Tablets in 1 Strip |
| Prescribed For | Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Gastrointestinal Stromal Tumors |
| Expiry | December 2027 |
Indenza is an anti-cancer medication that contains Enzalutamide 40mg, used primarily in the treatment of prostate cancer.
| Composition | Enzalutamide 40mg |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 112 Capsules |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Lenvakast contains Lenvatinib 10mg, a targeted therapy used in the treatment of advanced thyroid cancer, renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer).
| Composition | Lenvatinib |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 30 Capsules |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Sofokast Plus Tablet is an oral antiviral medication combining Sofosbuvir 400 mg and Daclatasvir 60 mg, used in treating chronic hepatitis C virus (HCV) infection.
| Composition | Sofosbuvir 400 mg and Daclatasvir 60 mg |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 28 Tablets in 1 Bottle |
| Prescribed For | HCV Infection |
| Expiry | December 2027 |
Sorafekast 200mg contains Sorafenib, a targeted cancer therapy used in the treatment of advanced liver cancer (Hepatocellular Carcinoma), kidney cancer (Renal Cell Carcinoma), and certain types of thyroid cancer.
| Composition | Sorafenib (200mg) |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | Liver Cancer, Kidney Cancer and Thyroid Cancer |
| Expiry | December 2027 |
Tudobest 300 mg Tablet contains Tenofovir Disoproxil Fumarate, an antiretroviral medication used in the treatment of HIV-1 infection and chronic hepatitis B virus (HBV) infection.
| Composition | Tenofovir Disoproxil Fumarate |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV-1 infection |
| Expiry | December 2027 |
Velakast Tablet is a fixed-dose combination of Sofosbuvir (400 mg) and Velpatasvir (100 mg), used for the treatment of chronic hepatitis C virus (HCV) infection in adults.
| Composition | Sofosbuvir 400 mg and Velpatasvir 100 mg |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
| Composition | Dasatinib |
| Manufacturer | Aprazer Healthcare Pvt ltd |
| Packing | 60 Tablets |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
Dacikast 60mg contains Daclatasvir Dihydrochloride, an antiviral medication used in the treatment of chronic Hepatitis C virus (HCV) infection.
| Composition | Daclatasvir |
| Manufacturer | Aprazer Healthcare Pvt ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Cycokast 50mg Injection contains Cisplatin, a platinum-based chemotherapy drug used to treat various types of cancer, including bladder, ovarian, testicular, lung, and cervical cancers.
| Composition | Cisplatin |
| Manufacturer | Aprazer Healthcare Pvt ltd |
| Packing | 1 Vial |
| Prescribed For | Anti-cancer |
| Expiry | December 2027 |
Bosenzer 125 mg contains bosentan, and it is primarily used to treat pulmonary arterial hypertension (PAH)—a type of high blood pressure that affects the arteries in the lungs and the right side of the heart.
| Composition | Bosentan |
| Manufacturer | Aprazer Healthcare Pvt ltd |
| Packing | 20 Tablets |
| Prescribed For | Hypertension |
| Expiry | December 2027 |
Abirakast 250mg Tablet contains Abiraterone Acetate and is primarily used in the treatment of advanced prostate cancer.
| Composition | Abiraterone Acetate (250mg) |
| Manufacturer | Aprazer Healthcare Pvt. Ltd. |
| Packing | 120 tablets in 1 bottle |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Aprazer Healthcare Pvt. Ltd. is a fast-growing pharmaceutical company based in India, dedicated to delivering high-quality, affordable medications across the globe. Specializing in the manufacture and export of generic and branded medicines, Aprazer is committed to improving patient outcomes through reliable and innovative healthcare solutions.
With a strong portfolio in oncology, virology, and chronic care segments, Aprazer Healthcare complies with global regulatory standards and partners with certified manufacturers to ensure product quality and patient safety. The company has a growing global footprint and serves healthcare providers, distributors, and pharmacies in over 50 countries.
